Literature DB >> 23205287

Advances in the treatment of pulmonary tuberculosis.

Xia Zhang1, Jing Guo.   

Abstract

Entities:  

Year:  2012        PMID： 23205287      PMCID： PMC3506809          DOI： 10.3978/j.issn.2072-1439.2012.10.10

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  41 in total

1.  Formation of dTDP-rhamnose is essential for growth of mycobacteria.

Authors:  Yufang Ma; Fei Pan; Michael McNeil
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

2.  Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.

Authors:  Mirko Zimic; Patricia Fuentes; Robert H Gilman; Andrés H Gutiérrez; Daniela Kirwan; Patricia Sheen
Journal:  Tuberculosis (Edinb)       Date:  2011-10-17       Impact factor: 3.131

3.  Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.

Authors:  J Mehta; I S Gandhi; S B Sane; M N Wamburkar
Journal:  Lepr Rev       Date:  1986       Impact factor: 0.537

4.  Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.

Authors:  Radha K Shandil; Ramesh Jayaram; Parvinder Kaur; Sheshagiri Gaonkar; B L Suresh; B N Mahesh; R Jayashree; Vrinda Nandi; Sowmya Bharath; V Balasubramanian
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

5.  Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?

Authors:  N Lounis; B Ji; C Truffot-Pernot; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

6.  Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes.

Authors:  Kirsty J McLean; Ker R Marshall; Alison Richmond; Iain S Hunter; Kay Fowler; Tobias Kieser; Sudagar S Gurcha; Gurydal S Besra; Andrew W Munro
Journal:  Microbiology       Date:  2002-10       Impact factor: 2.777

7.  Chemotherapeutic evaluation of alginate nanoparticle-encapsulated azole antifungal and antitubercular drugs against murine tuberculosis.

Authors:  Zahoor Ahmad; Sadhna Sharma; Gopal K Khuller
Journal:  Nanomedicine       Date:  2007-07-24       Impact factor: 5.307

8.  Molecular structure of EmbR, a response element of Ser/Thr kinase signaling in Mycobacterium tuberculosis.

Authors:  Luke J Alderwick; Virginie Molle; Laurent Kremer; Alain J Cozzone; Timothy R Dafforn; Gurdyal S Besra; Klaus Fütterer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

9.  Identification of a novel arabinofuranosyltransferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis.

Authors:  Luke J Alderwick; Mathias Seidel; Hermann Sahm; Gurdyal S Besra; Lothar Eggeling
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

10.  Biosynthesis of mycobacterial arabinogalactan: identification of a novel alpha(1-->3) arabinofuranosyltransferase.

Authors:  Helen L Birch; Luke J Alderwick; Apoorva Bhatt; Doris Rittmann; Karin Krumbach; Albel Singh; Yu Bai; Todd L Lowary; Lothar Eggeling; Gurdyal S Besra
Journal:  Mol Microbiol       Date:  2008-07-04       Impact factor: 3.501
View more
  1 in total

1.  Comparison of four DNA extraction methods for detecting Mycobacterium tuberculosis by real-time PCR and its clinical application in pulmonary tuberculosis.

Authors:  Shiyang Pan; Bing Gu; Hong Wang; Zihe Yan; Peng Wang; Hao Pei; Weiping Xie; Dan Chen; Genyan Liu
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.